St. Luke’s University Health Network has expanded its sleep medicine program with the addition of the remedē® System, an implantable therapy for adults with moderate to severe central sleep apnea.
St. Luke’s Sleep Medicine, part of St. Luke’s Neurosciences, recently became the first program in the region to offer the remedē System. The first two procedures were performed by Dr. Darren Traub, section chief of electrophysiology.
The remedē System is designed to treat central sleep apnea, a condition in which the brain does not send proper signals to the muscles that control breathing during sleep. The device monitors breathing patterns and delivers gentle stimulation to the phrenic nerve to help restore a more natural breathing rhythm…